570 related articles for article (PubMed ID: 18368606)
21. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts.
Boulard G
State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208
[No Abstract] [Full Text] [Related]
22. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
Maxwell JC; Rutkowski BA
Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
[TBL] [Abstract][Full Text] [Related]
23. Why do we need an Addiction supplement focused on methamphetamine?
Rawson RA; Condon TP
Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
[TBL] [Abstract][Full Text] [Related]
24. Electrocardiographic abnormalities in methamphetamine abusers.
Haning W; Goebert D
Addiction; 2007 Apr; 102 Suppl 1():70-5. PubMed ID: 17493055
[TBL] [Abstract][Full Text] [Related]
25. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users.
Lapworth K; Dawe S; Davis P; Kavanagh D; Young R; Saunders J
Addict Behav; 2009 Apr; 34(4):380-5. PubMed ID: 19097704
[TBL] [Abstract][Full Text] [Related]
26. A review of the clinical pharmacology of methamphetamine.
Cruickshank CC; Dyer KR
Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
[TBL] [Abstract][Full Text] [Related]
27. Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
Kaye S; Darke S; Duflou J; McKetin R
Addiction; 2008 Aug; 103(8):1353-60. PubMed ID: 18855825
[TBL] [Abstract][Full Text] [Related]
28. [Spontaneous recrudescence of psychotic diseases caused by methamphetamine (a stimulant): the stress type and the role of noradrenaline and dopamine systems].
Aburai K; Ikemoto U; Goto K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):319-20. PubMed ID: 15658512
[No Abstract] [Full Text] [Related]
29. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine.
van Gorp WG; Hinkin CH
Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716
[No Abstract] [Full Text] [Related]
30. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
Niwa M; Yan Y; Nabeshima T
Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
[TBL] [Abstract][Full Text] [Related]
31. The methamphetamine epidemic and dentistry.
Klasser GD; Epstein JB
Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
[TBL] [Abstract][Full Text] [Related]
32. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25.
Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
Addict Behav; 2007 May; 32(5):1003-15. PubMed ID: 16920275
[TBL] [Abstract][Full Text] [Related]
33. Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence.
Otani K; Ujike H; Sakai A; Okahisa Y; Kotaka T; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
Neurosci Lett; 2008 Mar; 434(1):88-92. PubMed ID: 18280655
[TBL] [Abstract][Full Text] [Related]
34. Oral manifestations of "meth mouth": a case report.
Turkyilmaz I
J Contemp Dent Pract; 2010 Jan; 11(1):E073-80. PubMed ID: 20098969
[TBL] [Abstract][Full Text] [Related]
35. [Stimulants related mental disorders].
Iyo M; Sekine Y
Ryoikibetsu Shokogun Shirizu; 2003; (40):507-12. PubMed ID: 14626172
[No Abstract] [Full Text] [Related]
36. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
[TBL] [Abstract][Full Text] [Related]
37. Meth mouth: methamphetamine and oral health.
Padilla R; Ritter AV
J Esthet Restor Dent; 2008; 20(2):148-9. PubMed ID: 18380848
[No Abstract] [Full Text] [Related]
38. Methamphetamine abuse and the impact on dental health.
Goodchild JH; Donaldson M; Mangini DJ
Dent Today; 2007 May; 26(5):124, 126, 128-31; quiz 131. PubMed ID: 17555197
[No Abstract] [Full Text] [Related]
39. [Role of cytokines in drug dependence].
Nakajima A; Yamada K; Nabeshima T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Aug; 23(4):179-82. PubMed ID: 13677913
[TBL] [Abstract][Full Text] [Related]
40. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
Volz TJ; Fleckenstein AE; Hanson GR
Addiction; 2007 Apr; 102 Suppl 1():44-8. PubMed ID: 17493052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
